Molecular Endocrinology, Vol 6, 694-702, Copyright © 1992 by Endocrine Society

ARTICLES

Characterization of the binding of transforming growth factor-beta 1, - beta 2, and -beta 3 to recombinant beta 1-latency-associated peptide

DM Miller, Y Ogawa, KK Iwata, P ten Dijke, AF Purchio, MS Soloff and LE Gentry
Department of Biochemistry and Molecular Biology, Medical College of Ohio, Toledo 43699.

Preprotransforming growth factor-beta 1 (TGF beta 1) is a 390-amino acid precursor polypeptide that undergoes a number of processing steps to yield mature TGF beta 1 (amino acid residues 279-390) and a pro portion (residues 30-278) termed beta 1-latency-associated peptide (beta 1LAP). The dimeric form of beta 1LAP has been shown to associate noncovalently with the mature growth factor, resulting in inactivation of biological activity. To further characterize this interaction, the mature TGF beta 1 was radioiodinated and used to determine dissociation constants. A cross-linking method using the bifunctional covalent cross- linker bis-(sulfosuccinimidyl)suberate was found to be the best approach for measuring the amount of bound growth factor. The efficiency of cross-linking was constant within each experiment and varied between 45-55%. Saturation plots and their associated Scatchard analyses indicate apparent Kd values between 1.1-1.8 nM. Competition of TGF beta 1 binding to beta 1LAP by TGF beta 2 and TGF beta 3 (two closely related growth factors) revealed that the latter also bind beta 1LAP tightly, with apparent Kd values of 1.9 and 0.4 nM, respectively.

This article has been cited by other articles:

				D. Q. Tran, J. Andersson, R. Wang, H. Ramsey, D. Unutmaz, and E. M. Shevach GARP (LRRC32) is essential for the surface expression of latent TGF-{beta} on platelets and activated FOXP3+ regulatory T cells PNAS, August 11, 2009; 106(32): 13445 - 13450. [Abstract] [Full Text] [PDF]

				W. Wang, X. R. Huang, A. G. Li, F. Liu, J.-H. Li, L. D. Truong, X. J. Wang, and H. Y. Lan Signaling Mechanism of TGF-{beta}1 in Prevention of Renal Inflammation: Role of Smad7 J. Am. Soc. Nephrol., May 1, 2005; 16(5): 1371 - 1383. [Abstract] [Full Text] [PDF]

				A. Gualandris, J. P. Annes, M. Arese, I. Noguera, V. Jurukovski, and D. B. Rifkin The Latent Transforming Growth Factor-beta -binding Protein-1 Promotes In Vitro Differentiation of Embryonic Stem Cells into Endothelium Mol. Biol. Cell, December 1, 2000; 11(12): 4295 - 4308. [Abstract] [Full Text]

				S. M. F. Ribeiro, M. Poczatek, S. Schultz-Cherry, M. Villain, and J. E. Murphy-Ullrich The Activation Sequence of Thrombospondin-1 Interacts with the Latency-associated Peptide to Regulate Activation of Latent Transforming Growth Factor-beta J. Biol. Chem., May 7, 1999; 274(19): 13586 - 13593. [Abstract] [Full Text] [PDF]

				L. Sun and C. Chen Expression of Transforming Growth Factor beta  Type III Receptor Suppresses Tumorigenicity of Human Breast Cancer MDA-MB-231 Cells J. Biol. Chem., October 3, 1997; 272(40): 25367 - 25372. [Abstract] [Full Text] [PDF]

				J. Kropf, J. O. Schurek, A. Wollner, and A. M. Gressner Immunological measurement of transforming growth factor-beta 1 (TGF-ß1) in blood; assay development and comparison Clin. Chem., October 1, 1997; 43(10): 1965 - 1974. [Abstract] [Full Text] [PDF]

				S. Bailly, C. Brand, E. M. Chambaz, and J.-J. Feige Analysis of Small Latent Transforming Growth Factor-beta Complex Formation and Dissociation by Surface Plasmon Resonance. ABSENCE OF DIRECT INTERACTION WITH THROMBOSPONDINS J. Biol. Chem., June 27, 1997; 272(26): 16329 - 16334. [Abstract] [Full Text] [PDF]

				T. Brand and M. D. Schneider Inactive Type II and Type I Receptors for TGFbeta Are Dominant Inhibitors of TGFbeta-dependent Transcription J. Biol. Chem., April 7, 1995; 270(14): 8274 - 8284. [Abstract] [Full Text] [PDF]